Vertex Pharmaceuticals Statistics
Total Valuation
LON:0QZU has a market cap or net worth of GBP 80.80 billion. The enterprise value is 72.87 billion.
| Market Cap | 80.80B | 
| Enterprise Value | 72.87B | 
Important Dates
The next estimated earnings date is Monday, November 3, 2025.
| Earnings Date | Nov 3, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
| Current Share Class | 256.39M | 
| Shares Outstanding | n/a | 
| Shares Change (YoY) | +0.19% | 
| Shares Change (QoQ) | -0.23% | 
| Owned by Insiders (%) | 0.20% | 
| Owned by Institutions (%) | 96.40% | 
| Float | 255.58M | 
Valuation Ratios
The trailing PE ratio is 30.43 and the forward PE ratio is 21.40.
| PE Ratio | 30.43 | 
| Forward PE | 21.40 | 
| PS Ratio | 9.69 | 
| PB Ratio | 6.45 | 
| P/TBV Ratio | 7.07 | 
| P/FCF Ratio | 31.63 | 
| P/OCF Ratio | 28.78 | 
| PEG Ratio | n/a | 
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.19, with an EV/FCF ratio of 28.53.
| EV / Earnings | 27.45 | 
| EV / Sales | 8.45 | 
| EV / EBITDA | 20.19 | 
| EV / EBIT | 21.78 | 
| EV / FCF | 28.53 | 
Financial Position
The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.52 | 
| Quick Ratio | 2.00 | 
| Debt / Equity | 0.09 | 
| Debt / EBITDA | 0.32 | 
| Debt / FCF | 0.44 | 
| Interest Coverage | 260.54 | 
Financial Efficiency
Return on equity (ROE) is 22.77% and return on invested capital (ROIC) is 16.09%.
| Return on Equity (ROE) | 22.77% | 
| Return on Assets (ROA) | 12.53% | 
| Return on Invested Capital (ROIC) | 16.09% | 
| Return on Capital Employed (ROCE) | 22.26% | 
| Revenue Per Employee | 1.37M | 
| Profits Per Employee | 435,260 | 
| Employee Count | 6,100 | 
| Asset Turnover | 0.52 | 
| Inventory Turnover | 4.49 | 
Taxes
In the past 12 months, LON:0QZU has paid 537.50 million in taxes.
| Income Tax | 537.50M | 
| Effective Tax Rate | 16.84% | 
Stock Price Statistics
The stock price has decreased by -12.32% in the last 52 weeks. The beta is 0.43, so LON:0QZU's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 | 
| 52-Week Price Change | -12.32% | 
| 50-Day Moving Average | 400.73 | 
| 200-Day Moving Average | 445.58 | 
| Relative Strength Index (RSI) | 54.64 | 
| Average Volume (20 Days) | 444 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | 1.95 | 
Income Statement
In the last 12 months, LON:0QZU had revenue of GBP 8.33 billion and earned 2.66 billion in profits. Earnings per share was 10.27.
| Revenue | 8.33B | 
| Gross Profit | 4.38B | 
| Operating Income | 3.23B | 
| Pretax Income | 3.19B | 
| Net Income | 2.66B | 
| EBITDA | 3.36B | 
| EBIT | 3.23B | 
| Earnings Per Share (EPS) | 10.27 | 
Balance Sheet
The company has 4.66 billion in cash and 1.11 billion in debt, giving a net cash position of 7.66 billion.
| Cash & Cash Equivalents | 4.66B | 
| Total Debt | 1.11B | 
| Net Cash | 7.66B | 
| Net Cash Per Share | n/a | 
| Equity (Book Value) | 12.54B | 
| Book Value Per Share | 48.91 | 
| Working Capital | 4.59B | 
Cash Flow
In the last 12 months, operating cash flow was 2.81 billion and capital expenditures -253.06 million, giving a free cash flow of 2.55 billion.
| Operating Cash Flow | 2.81B | 
| Capital Expenditures | -253.06M | 
| Free Cash Flow | 2.55B | 
| FCF Per Share | n/a | 
Margins
Gross margin is 52.54%, with operating and profit margins of 38.79% and 31.86%.
| Gross Margin | 52.54% | 
| Operating Margin | 38.79% | 
| Pretax Margin | 38.31% | 
| Profit Margin | 31.86% | 
| EBITDA Margin | 40.32% | 
| EBIT Margin | 38.79% | 
| FCF Margin | 30.65% | 
Dividends & Yields
LON:0QZU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -0.19% | 
| Shareholder Yield | -0.19% | 
| Earnings Yield | 3.29% | 
| FCF Yield | 3.16% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
LON:0QZU has an Altman Z-Score of 12.59 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.59 | 
| Piotroski F-Score | 5 |